Alcon AG (NYSE:ALC) saw its stock fall more than 2% on Thursday following a rating cut by J.P. Morgan, citing disappointing quarterly performance and reduced visibility on earnings. David Adlington, ...

J.P. Morgan downgraded Alcon (NYSE:ALC) to Neutral from Overweight on Thursday after the Swiss maker of intraocular lenses reported Q2 2025 results falling short of Street forecasts for revenue ...

The analysts cut its rating on Alcon shares to “neutral” from “overweight” and lowered its price target to SFr 62.8 for June 2027, down from SFr 94.7 for June 2026. The reduced target reflects lower ...

Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...

JP Morgan’s European desk has upgraded Alcon (ALC) to overweight, commenting that concerns about growth in the implantables market is likely to be “short-lived.” Read more here.

JPMorgan analyst David Adlington lowered the firm’s price target on Alcon (ALC) to CHF 79.60 from CHF 84.30 and keeps an Overweight rating on the shares.Published first on TheFly – the ...